MediWound Ltd. (MDWD) stock
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$13.68+0.13 (+0.96%)
Close on Nov 17, 2026Market cap $175.58MP/E –Yield –
MediWound revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $16.96M, down 16.1% from the year before. Over ten years it grew 39.7% a year on average. The highest annual figure on record is $31.79M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.96M | -16.1% |
| FY2024 | Dec 31, 2024 | $20.22M | +8.2% |
| FY2023 | Dec 31, 2023 | $18.69M | -29.5% |
| FY2022 | Dec 31, 2022 | $26.50M | +11.5% |
| FY2021 | Dec 31, 2021 | $23.76M | +9.2% |
| FY2020 | Dec 31, 2020 | $21.76M | -31.5% |
| FY2019 | Dec 31, 2019 | $31.79M | +834.7% |
| FY2018 | Dec 31, 2018 | $3.40M | +36.3% |
| FY2017 | Dec 31, 2017 | $2.50M | +60.2% |
| FY2016 | Dec 31, 2016 | $1.56M | +159.2% |
| FY2015 | Dec 31, 2015 | $601.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.09M | -33.8% |
| Q2 FY2025 | Jun 30, 2025 | $5.71M | -5.8% |
| Q2 FY2024 | Jun 30, 2024 | $5.06M | +25.7% |
| Q2 FY2023 | Jun 30, 2023 | $4.77M | -77.0% |
| Q2 FY2022 | Jun 30, 2022 | $4.67M | +352.8% |
| Q2 FY2021 | Jun 30, 2021 | $6.06M | +781.7% |
| Q2 FY2020 | Jun 30, 2020 | $4.03M | – |
| Q2 FY2019 | Jun 30, 2019 | $20.75M | – |
| Q2 FY2018 | Jun 30, 2018 | $1.03M | – |
| Q2 FY2017 | Jun 30, 2017 | $687.00K | – |
See a number that looks wrong?